HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Comi Selected Research

Cardiotoxicity

10/2009Mitoxantrone: benefits and risks in multiple sclerosis patients.
10/2005Mitoxantrone for multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Comi Research Topics

Disease

70Multiple Sclerosis
01/2022 - 01/2000
22Relapsing-Remitting Multiple Sclerosis
10/2021 - 06/2000
8Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2014 - 07/2000
8Demyelinating Diseases (Demyelinating Disease)
03/2010 - 01/2000
7Chronic Progressive Multiple Sclerosis
10/2017 - 06/2000
6Disease Progression
10/2009 - 08/2001
5Infections
11/2020 - 09/2002
4Herpes Simplex
11/2020 - 07/2000
4Fatigue
11/2015 - 06/2001
4Headache (Headaches)
10/2015 - 10/2004
4Parkinson Disease (Parkinson's Disease)
03/2014 - 02/2001
3Neoplasms (Cancer)
11/2020 - 05/2011
3Autoimmune Diseases (Autoimmune Disease)
01/2019 - 05/2000
3Neuromyelitis Optica (Devic's Disease)
09/2016 - 10/2009
3Atrophy
05/2014 - 03/2004
3Encephalomyelitis (Myeloencephalitis)
06/2004 - 01/2001
2Herpes Zoster
11/2020 - 05/2011
2Lymphopenia (Lymphocytopenia)
11/2020 - 05/2011
2Migraine Disorders (Migraine)
10/2015 - 10/2004
2Alzheimer Disease (Alzheimer's Disease)
05/2014 - 04/2014
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
07/2011 - 03/2000
2Pathologic Constriction (Stenosis)
02/2011 - 12/2010
2Inflammation (Inflammations)
02/2011 - 10/2007
2Psychotic Disorders (Schizoaffective Disorder)
12/2010 - 08/2001
2Injection Site Reaction
10/2009 - 10/2009
2Cardiotoxicity
10/2009 - 10/2005
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
10/2003 - 08/2001
1Muscle Spasticity (Spastic)
01/2020
1Hemophilia A (Haemophilia)
01/2019
1Parkinsonian Disorders (Parkinsonism)
01/2017
1Agammaglobulinemia (Hypogammaglobulinemia)
04/2016
1Leukopenia
04/2016
1Ataxia (Dyssynergia)
01/2016
1Vertigo (Positional Vertigo)
10/2015
1Chronic Disease (Chronic Diseases)
05/2014
1Pain (Aches)
05/2014
1Neuroinflammatory Diseases
04/2014
1Schizophrenia (Dementia Praecox)
01/2014
1Aphasia (Dysphasia)
04/2013
1Apraxias (Dyspraxia)
04/2013
1Hemifacial Spasm
02/2013

Drug/Important Bio-Agent (IBA)

14Glatiramer Acetate (Copaxone)FDA Link
01/2015 - 06/2000
12Interferon-betaIBA
01/2017 - 06/2000
9CytokinesIBA
01/2022 - 01/2000
9Pharmaceutical PreparationsIBA
10/2021 - 10/2004
9InterferonsIBA
01/2017 - 11/2000
8Fingolimod Hydrochloride (FTY720)FDA Link
10/2021 - 01/2009
7Natalizumab (Tysabri)FDA Link
01/2016 - 10/2009
5Interferon beta-1aFDA Link
06/2007 - 06/2000
4Interferon beta-1b (Betaseron)FDA Link
01/2014 - 06/2000
4Mitoxantrone (Novantrone)FDA LinkGeneric
12/2011 - 10/2005
4Interleukin-4 (Interleukin 4)IBA
04/2008 - 11/2000
3TabletsIBA
11/2020 - 05/2011
3CladribineFDA LinkGeneric
11/2020 - 05/2000
3nabiximols (Sativex)IBA
01/2018 - 09/2011
3Biomarkers (Surrogate Marker)IBA
11/2017 - 05/2014
3Proteins (Proteins, Gene)FDA Link
05/2014 - 06/2004
2AntibodiesIBA
01/2022 - 10/2009
2Alemtuzumab (Campath)FDA Link
06/2020 - 01/2019
2CannabinoidsIBA
01/2018 - 09/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 07/2012
2Rituximab (Mabthera)FDA Link
09/2016 - 04/2016
2teriflunomideIBA
01/2015 - 06/2012
2Botulinum Toxins (Botulinum Toxin)IBA
02/2013 - 08/2001
2laquinimodIBA
11/2010 - 06/2008
2Protons (Proton)IBA
11/2005 - 02/2003
2Immunoglobulins (Immunoglobulin)IBA
06/2004 - 10/2003
2Intravenous Immunoglobulins (IVIG)FDA Link
10/2003 - 08/2001
2beta-Endorphin (Endorphin, beta)IBA
04/2003 - 08/2000
2InterleukinsIBA
01/2001 - 07/2000
1AntigensIBA
01/2022
1ofatumumabFDA Link
01/2022
1Monoclonal AntibodiesIBA
01/2019
1Vitamin DFDA LinkGeneric
08/2018
1hydroxide ionIBA
08/2018
125-hydroxyvitamin DIBA
08/2018
1CannabidiolIBA
09/2016
1Dronabinol (THC)FDA LinkGeneric
09/2016
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2015
1Cinnarizine (Cinna)IBA
10/2015
1Dimenhydrinate (DMH)FDA LinkGeneric
10/2015
1AnticoagulantsIBA
05/2015
1Therapeutic UsesIBA
05/2014
1Amyloid beta-PeptidesIBA
05/2014
1tau Proteins (tau Protein)IBA
05/2014
1Amyloid (Amyloid Fibrils)IBA
04/2014
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2014
1Angiotensin Receptor AntagonistsIBA
01/2014
1Antipsychotic Agents (Antipsychotics)IBA
01/2014
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2014
1technetium Tc 99m bicisate (Neurolite)FDA Link
04/2013

Therapy/Procedure

25Therapeutics
01/2017 - 01/2000
4Injections
01/2020 - 08/2001
2Transcranial Magnetic Stimulation
03/2014 - 07/2000
2Stem Cell Transplantation
04/2004 - 05/2000
1Subcutaneous Injections
01/2022
1Physical Therapy Modalities (Physical Therapy Technique)
01/2020
1Surgical Instruments (Clip)
10/2014
1Complementary Therapies (Alternative Medicine)
05/2014
1Duration of Therapy
05/2014